HSBC Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.36M | Sell |
148,182
-352,814
| -70% | -$20.6M | ﹤0.01% | 982 |
|
|
2025
Q4 | $29.8M | Buy |
500,996
+220,995
| +79% | +$12M | 0.02% | 631 |
|
|
2025
Q3 | $15.1M | Sell |
280,001
-93,116
| -25% | -$5.33M | 0.01% | 796 |
|
|
2025
Q2 | $20.5M | Buy |
373,117
+47,083
| +14% | +$2.77M | 0.01% | 702 |
|
|
2025
Q1 | $23M | Buy |
326,034
+130,504
| +67% | +$8.78M | 0.01% | 671 |
|
|
2024
Q4 | $12.8M | Sell |
195,530
-4,865
| -2% | -$326K | 0.01% | 854 |
|
|
2024
Q3 | $14.1M | Buy |
200,395
+110,600
| +123% | +$9.25M | 0.01% | 826 |
|
|
2024
Q2 | $7.41M | Sell |
89,795
-142,903
| -61% | -$11.9M | ﹤0.01% | 943 |
|
|
2024
Q1 | $20.3M | Sell |
232,698
-196,359
| -46% | -$17.6M | 0.01% | 695 |
|
|
2023
Q4 | $41.3M | Sell |
429,057
-178,041
| -29% | -$15.8M | 0.04% | 467 |
|
|
2023
Q3 | $53.9M | Buy |
607,098
+434,199
| +251% | +$38.6M | 0.06% | 345 |
|
|
2023
Q2 | $15M | Sell |
172,899
-18,888
| -10% | -$1.78M | 0.02% | 700 |
|
|
2023
Q1 | $18.7M | Sell |
191,787
-104,788
| -35% | -$10.9M | 0.02% | 634 |
|
|
2022
Q4 | $30.4M | Buy |
296,575
+195,495
| +193% | +$18.4M | 0.03% | 505 |
|
|
2022
Q3 | $8.62M | Buy |
101,080
+44,955
| +80% | +$4M | 0.01% | 946 |
|
|
2022
Q2 | $4.68M | Sell |
56,125
-28,150
| -33% | -$2.24M | 0.01% | 1224 |
|
|
2022
Q1 | $6.53M | Buy |
84,275
+34,713
| +70% | +$2.9M | 0.01% | 1081 |
|
|
2021
Q4 | $4.41M | Sell |
49,562
-35,335
| -42% | -$2.92M | ﹤0.01% | 1320 |
|
|
2021
Q3 | $6.56M | Buy |
84,897
+31,007
| +58% | +$2.45M | 0.01% | 1044 |
|
|
2021
Q2 | $4.49M | Buy |
53,890
+11,160
| +26% | +$885K | ﹤0.01% | 1143 |
|
|
2021
Q1 | $3.23M | Sell |
42,730
-5,478
| -11% | -$447K | ﹤0.01% | 1156 |
|
|
2020
Q4 | $4.2M | Sell |
48,208
-21,535
| -31% | -$1.71M | 0.01% | 1090 |
|
|
2020
Q3 | $5.33M | Buy |
69,743
+27,931
| +67% | +$2.83M | 0.01% | 927 |
|
|
2020
Q2 | $5.16M | Sell |
41,812
-11,739
| -22% | -$1.17M | 0.01% | 850 |
|
|
2020
Q1 | $4.49M | Buy |
53,551
+20,266
| +61% | +$1.75M | 0.01% | 886 |
|
|
2019
Q4 | $2.82M | Sell |
33,285
-8,285
| -20% | -$626K | ﹤0.01% | 1365 |
|
|
2019
Q3 | $2.8M | Buy |
41,570
+15,493
| +59% | +$1.19M | 0.01% | 1446 |
|
|
2019
Q2 | $2.23M | Sell |
26,077
-11,107
| -30% | -$950K | ﹤0.01% | 1480 |
|
|
2019
Q1 | $3.3M | Sell |
37,184
-238,585
| -87% | -$22.1M | 0.01% | 1283 |
|
|
2018
Q4 | $23.5M | Buy |
275,769
+55,006
| +25% | +$5.23M | 0.04% | 433 |
|
|
2018
Q3 | $21.4M | Buy |
220,763
+199,861
| +956% | +$19.9M | 0.03% | 524 |
|
|
2018
Q2 | $1.97M | Sell |
20,902
-16,890
| -45% | -$1.48M | ﹤0.01% | 1510 |
|
|
2018
Q1 | $3.06M | Sell |
37,792
-1,450
| -4% | -$124K | ﹤0.01% | 1285 |
|
|
2017
Q4 | $3.5M | Buy |
39,242
+13,724
| +54% | +$1.19M | 0.01% | 951 |
|
|
2017
Q3 | $2.37M | Sell |
25,518
-720
| -3% | -$63.6K | ﹤0.01% | 1260 |
|
|
2017
Q2 | $2.38M | Buy |
26,238
+8,184
| +45% | +$745K | ﹤0.01% | 1221 |
|
|
2017
Q1 | $1.59M | Sell |
18,054
-18,635
| -51% | -$1.66M | ﹤0.01% | 1283 |
|
|
2016
Q4 | $3.04M | Sell |
36,689
-6,903
| -16% | -$594K | 0.01% | 1104 |
|
|
2016
Q3 | $4.03M | Sell |
43,592
-4,858
| -10% | -$457K | 0.01% | 970 |
|
|
2016
Q2 | $3.77M | Sell |
48,450
-32,585
| -40% | -$2.77M | 0.01% | 1005 |
|
|
2016
Q1 | $6.68M | Sell |
81,035
-125
| -0.2% | -$10.2K | 0.02% | 786 |
|
|
2015
Q4 | $8.5M | Sell |
81,160
-19,406
| -19% | -$2.03M | 0.02% | 747 |
|
|
2015
Q3 | $10.6M | Sell |
100,566
-3,741
| -4% | -$500K | 0.03% | 581 |
|
|
2015
Q2 | $14.2M | Buy |
104,307
+42,580
| +69% | +$5.28M | 0.03% | 528 |
|
|
2015
Q1 | $7.69M | Buy |
61,727
+10,967
| +22% | +$1.16M | 0.01% | 765 |
|
|
2014
Q4 | $4.59M | Buy |
50,760
+14,280
| +39% | +$1.19M | 0.01% | 923 |
|
|
2014
Q3 | $2.63M | Sell |
36,480
-296,822
| -89% | -$19.5M | 0.01% | 1078 |
|
|
2014
Q2 | $20.7M | Buy |
333,302
+98,803
| +42% | +$5.97M | 0.04% | 404 |
|
|
2014
Q1 | $16M | Buy |
234,499
+218,010
| +1,322% | +$16.1M | 0.04% | 429 |
|
|
2013
Q4 | $1.16M | Buy |
16,489
+6,098
| +59% | +$414K | ﹤0.01% | 1232 |
|
|
2013
Q3 | $750K | Buy |
10,391
+8,438
| +432% | +$561K | ﹤0.01% | 1294 |
|
|
2013
Q2 | $109K | Buy |
+1,953
| New | +$122K | ﹤0.01% | 1492 |
|
Other funds holding BMRN
VCM
VPM
HSBC Holdings's BMRN Position: Q1 2026 in Review
HSBC Holdings reduced its BioMarin Pharmaceuticals (BMRN) stake by 70% in Q1 2026, selling an estimated $20.6M and leaving 148,182 shares worth $8.36M. The position accounts for ﹤0.01% of the portfolio, ranked #982.
HSBC Holdings first reported a position in BMRN in Q2 2013 and has held it in 52 quarters since. The position peaked at $53.9M in Q3 2023. 555 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.
- HSBC Holdings held 148,182 shares of BioMarin Pharmaceuticals worth $8.36M as of Q1 2026.
- HSBC Holdings sold 352,814 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $20.6M.
- BioMarin Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #982 holding.
- HSBC Holdings first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's BioMarin Pharmaceuticals position peaked at $53.9M in Q3 2023.
- 555 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.